ProShare Advisors’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

ProShare Advisors’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,623	Closed	-$376K	–	2038
2024 Q1	$376K	Buy	+17,623	New	+$211K	﹤0.01%	1272

ProShare Advisors's FUSN Position: Q2 2024 in Review

ProShare Advisors sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 17,623 shares — an estimated $376K sold.

ProShare Advisors first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $376K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

ProShare Advisors reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
ProShare Advisors sold 17,623 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $376K.
ProShare Advisors first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
ProShare Advisors's Fusion Pharmaceuticals Inc. Common Shares position peaked at $376K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on ProShare Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.